Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
Abstract Background Focal segmental glomerulosclerosis (FSGS) is a chronic glomerular disease that responds poorly to treatment, with a large proportion of patients progressing to end-stage renal disease in spite of initial aggressive treatment. It is worth emphasizing that the FSGS group has still...
Main Authors: | Phuong Anh Le Thy, Thuy Yen Hoang Thi, Kiem Hao Tran, Huu Son Nguyen |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-09-01
|
Series: | Egyptian Pediatric Association Gazette |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43054-022-00117-y |
Similar Items
-
Urinary CD80 and Serum suPAR as Biomarkers of Glomerular Disease among Adults in Brazil
by: Renata de Cássia Zen, et al.
Published: (2023-01-01) -
Soluble urokinase-type plasminogen activator receptor as a biomarker for focal segmental glomerulosclerosis; a retrospective analysis
by: Miguel Verdelho, et al.
Published: (2018-07-01) -
Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
by: Dimitrios Velissaris, et al.
Published: (2022-09-01) -
Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection
by: Sebastian M. Klim, et al.
Published: (2024-02-01) -
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
by: Burcin Özdirik, et al.
Published: (2020-05-01)